Lv2
180 积分 2020-11-12 加入
Imipenem–cilastatin–funobactam versus imipenem–cilastatin–relebactam in patients with hospital-acquired bacterial pneumonia or ventilator-associated bacterial pneumonia: a phase 3, double-blind, non-inferiority randomised trial
1小时前
已完结
The Surgical Infection Society Guidelines on the Management of Intra-Abdominal Infection: 2024 Update
1个月前
已完结
Effectiveness of Sulbactam/Durlobactam in carbapenem-resistant Acinetobacter baumannii pulmonary infection complicated with carbapenem-resistant Enterobacterales and/or carbapenem-resistant Pseudomonas aeruginosa infection: A prospective, multicenter, cohort study
4个月前
已完结
An update on antimicrobial selection and duration for intra-abdominal infections
6个月前
已完结
How do I manage difficult-to-treat Pseudomonas aeruginosa infections? Key questions for today’s clinicians
6个月前
已完结
Current Management Strategies of Difficult-to-Treat Resistant Pseudomonas aeruginosa Infections
6个月前
已关闭
cirA promoter disruption and SHV-12 production contribute to cefiderocol resistance in carbapenem-resistant Klebsiella pneumoniae
6个月前
已完结
Emergence of Carbapenem-Resistant Escherichia coli Coharboring bla CTX-M-199 and Penicillin-Binding Protein 3 Insertion Conferring Increased Aztreonam/Avibactam Resistance in South China
6个月前
已完结
Aztreonam-Avibactam Resistance Due to Synergistic Interplay of ampC-Related Mutations in Carbapenem-Resistant Enterobacter spp
6个月前
已关闭
Comparison of Ceftolozane-Tazobactam and Ceftazidime-Avibactam in the Treatment of Multidrug-Resistant/Difficult-to-Treat Resistant Pseudomonas aeruginosa Infections: A Systematic Review and Meta-analysis
6个月前
已完结